Confirming the involvement of RANKL in the initial oncogenic process, administration of RANK-Fc decreased both mammary tumorigenesis and the development of lung metastases in MMTV-neu transgenic mice, a spontaneous mammary tumour model [122]. Here, TNFSF11 is linked to breast cancer.